Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
DANVERS, Mass., July 28, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), penyedia utama teknologi dukungan jantung tingkat lanjut hari ini melaporkan pendapatan fiskal tahun 2018 kuartal...
-
Abiomed Mengumumkan Pendapatan S1 TF 2018 sebanyak $132.5 Juta, Naik 29% Berbanding Tahun Sebelumnya
DANVERS, Mass., July 28, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), pembekal terkemuka teknologi sokongan hati cemerlang, hari ini melaporkan pendapatan suku pertama tahun fiskal 2018...
-
DANVERS, Mass., July 27, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today reported first quarter fiscal 2018 revenue of...
-
DANVERS, Mass., July 06, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD) announced that on Thursday, July 27, 2017, the Company will release financial results for the first quarter of fiscal...
-
DANVERS, Mass., June 30, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, announced today the recent publication of a...
-
WASHINGTON, June 09, 2017 (GLOBE NEWSWIRE) -- Nineteen patients who benefitted from treatment with Abiomed’s Impella heart pumps traveled to Washington, D.C. on June 8, 2017, to meet with elected...
-
DANVERS, Mass., May 30, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman,...
-
DANVERS, Mass., May 09, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, announced the debut of the 3rd Generation...
-
DANVERS, Mass., May 08, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), un proveedor líder de tecnologías innovadoras para asistencia cardíaca, anunció ingresos de $124,7 millones para el...
-
马萨诸塞州丹佛斯, May 08, 2017 (GLOBE NEWSWIRE) -- Abiomed 公司（纳斯达克编号：ABMD）是突破性心脏支架技术的领先供应商，它今天宣布 2017 财年第四季度收入达到 1.247 亿美元，比 2016 年同期的 9,400 万美元收入增长 33%。2017 财年的总收入为 4.453 亿美元，比 2016 年的 3.295 亿美元收入增长 35%。在...